How environmental factors affect diabetes development in Latinos
SOLAir: Environmental Factors and Diabetes Development in Latinos
This study is looking at how things like air pollution might affect the risk of developing Type 2 diabetes in Latino communities, and it’s for people who want to understand how their environment and lifestyle choices could impact their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10911998 on NIH RePORTER |
What this research studies
This research investigates the relationship between environmental factors, particularly air pollution, and the development of Type 2 diabetes in Latino populations. By utilizing advanced environmental exposure assessments alongside health measures, the study aims to identify how factors like traffic-related air pollutants and community environments contribute to diabetes risk. Participants will be drawn from the Hispanic Community Health Study, which provides extensive health data, allowing for a thorough analysis of these interactions. The research seeks to understand how these environmental influences may interact with lifestyle factors such as diet and physical activity.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latino adults, particularly those living in urban areas with varying levels of air pollution.
Not a fit: Patients who are not Latino or those who do not reside in urban environments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for diabetes prevention and management in Latino communities.
How similar studies have performed: Previous studies have shown varying results regarding the impact of environmental factors on diabetes, indicating that this research could provide valuable new insights.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Kaufman, Joel Daniel — University of Washington
- Study coordinator: Kaufman, Joel Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.